Skip to main content
. 2018 May 8;2018:4874193. doi: 10.1155/2018/4874193

(a) Categorical variables

Variable PC (%) NSCLC (%)
Gender
 Men 53.0% 63.4%
 Women 47.0% 36.6%
Radiotherapy 13.4% 69.0%
Chemotherapy 73.3% 76.0%
Surgery 40.1% 10.0%
Stage
 Stage 1 11.3%
 Stage 2 7.0%
 Stage 3 21.1%
 Stage 4 60.6%